中国维生素月报

Company dynamic

• On 30 Dec., 2025, Vitality released its third-quarter results for the nine months ended 31 October, 2025.
• On 4 Jan., 2026, Zhenhua Chemical announced its plan to raise funds through the issuance of convertible bonds.
• On 6 Jan., 2026, Yifan Pharmaceutical obtained the Drug Registration Certificate for Vitamin K1 injection from the NMPA.
• On 8 Jan., 2026, Kingdomway has reallocated the funds from its convertible bonds from the allulose and inositol project to an oil project and a healthcare product factory project.
• On 9 Jan., 2026, iHerb completed the acquisition of Vitacost.

Project progress

• EI report for Ya'an Giantstar's feed factory project (Phase I) was accepted.
• EI report for Chifeng Pharma's vitamin B2 and griseofulvin relocation and upgrade project was accepted.
• EI report for Bihai Animal Husbandry's the vitamin K3 series products project was accepted.

The USD/RMB exchange rate in this Report is USD1.00=CNY7.0230 on 5 Jan. 2026, sourced from the People's Bank of China. All the prices mentioned in this Report will include the VAT, unless otherwise specified.